Stockscreener 앱 받기
5.70
3.06%
-0.18
시간 외 거래:
5.63
-0.07
-1.23%
전일 마감가:
$5.88
열려 있는:
$5.85
하루 거래량:
283.99K
Relative Volume:
1.03
시가총액:
$249.52M
수익:
-
순이익/손실:
$-54.19M
주가수익비율:
-2.2093
EPS:
-2.58
순현금흐름:
$-37.34M
1주 성능:
+2.89%
1개월 성능:
-5.00%
6개월 성능:
+28.96%
1년 성능:
+16.33%
1일 변동 폭
$5.67
$5.93
1주일 범위
$5.40
$6.06
52주 변동 폭
$3.05
$9.01
Abeona Therapeutics Inc Stock (ABEO) Company Profile
명칭
Abeona Therapeutics Inc
전화
646-813-4701
주소
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
ABEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.70 | 249.52M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 120.86B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-30 | 개시 | Stifel | Buy |
| 2020-11-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-02-10 | 개시 | SVB Leerink | Outperform |
| 2019-12-10 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-08-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2019-08-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2018-10-12 | 개시 | Mizuho | Buy |
| 2018-06-05 | 개시 | Seaport Global Securities | Buy |
| 2017-11-08 | 개시 | SunTrust | Buy |
| 2017-10-16 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-10-10 | 개시 | Citigroup | Buy |
| 2017-10-05 | 재확인 | Maxim Group | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-07-18 | 재확인 | Maxim Group | Buy |
| 2017-06-22 | 재개 | Jefferies | Buy |
| 2017-01-06 | 개시 | Jefferies | Buy |
| 2016-09-29 | 재확인 | Maxim Group | Buy |
모두보기
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit - Yahoo Finance
Dystrophic Epidermolysis Bullosa Market to Reach New Heights - openPR
Abeona Therapeutics (NASDAQ:ABEO) Raised to Hold at StockNews.com - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Director Sells $21,520.00 in Stock - MarketBeat
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Abeona's Strategic Move: 13,000 Restricted Shares Granted to Key New Hires - StockTitan
Insider Sell: Mark Alvino Sells 4,000 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus.com
JPMorgan Chase & Co. Buys 28,606 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
Abeona Therapeutics: Despite Some Competitive Pressure, This Looks Undervalued (ABEO) - Seeking Alpha
Mark Alvino Sells 4,000 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) Stock - MarketBeat
Abeona Therapeutics director Mark Alvino sells $20,400 in stock - Investing.com
(ABEO) Investment Analysis and Advice - Stock Traders Daily
Abeona Therapeutics Inc (NASDAQ:ABEO) Stake Cut by Barclays PLC - Defense World
Jane Street Group LLC Invests $84,000 in Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Stock Rating Lowered by StockNews.com - Defense World
(ABEO) Trading Advice - Stock Traders Daily
Abeona Therapeutics (NASDAQ:ABEO) Cut to Sell at StockNews.com - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Shares Acquired by Geode Capital Management LLC - Defense World
Abeona Therapeutics Inc (NASDAQ:ABEO) Shares Sold by Barclays PLC - Defense World
State Street Corp Sells 2,600 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
Global Mucopolysaccharidosis Treatment Market to Witness Robust Growth, Projected to Reach USD 5,014.5 Million by 2035 Growing at a CAGR of 5.9% | FMI - GlobeNewswire Inc.
Abeona Therapeutics Awards Equity Incentives to New Employees in Strategic Talent Acquisition Move - StockTitan
Abeona Therapeutics (NASDAQ:ABEO) Upgraded to "Hold" at StockNews.com - MarketBeat
StockNews.com Upgrades Abeona Therapeutics (NASDAQ:ABEO) to “Hold” - Defense World
Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO), - Yahoo Finance
Abeona Therapeutics Inc. Receives Stockholder Approval for Equity Incentive Plan Amendment - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Raised to “Hold” at StockNews.com - Defense World
StockNews.com Upgrades Abeona Therapeutics (NASDAQ:ABEO) to Hold - MarketBeat
(ABEO) On The My Stocks Page - Stock Traders Daily
Charles Schwab Investment Management Inc. Purchases Shares of 23,850 Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Rating Lowered to Sell at StockNews.com - MarketBeat
When the Price of (ABEO) Talks, People Listen - Stock Traders Daily
Abeona Therapeutics Inc (NASDAQ:ABEO) is Western Standard LLC's 3rd Largest Position - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Holdings Lowered by Ikarian Capital LLC - MarketBeat
Abeona Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - XM
Abeona Therapeutics announces new employee inducement grants - TipRanks
Abeona Therapeutics Grants 44,700 Restricted Shares to New Employees as Incentive - StockTitan
Walleye Capital LLC Sells 129,083 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) - MarketBeat
Abeona Therapeutics Inc.'s (NASDAQ:ABEO) large institutional owners must be happy as stock continues to impress, up 11% over the past week - Simply Wall St
What is HC Wainwright's Estimate for ABEO FY2024 Earnings? - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Shares Sold by Propel Bio Management LLC - MarketBeat
Abeona shares retain Buy rating; H.C. Wainwright sees approval potential for pz-cel in RDEB - Investing.com UK
Abeona Therapeutics (NASDAQ:ABEO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Earnings call: Abeona Therapeutics Q3 2024 results and PZ cell update - Investing.com Canada
Abeona Therapeutics Inc (ABEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
자본화:
|
볼륨(24시간):